Eli Lilly and Company reports $24.4 billion revenue for quarter ended September 30, 2026, up 38.6%

ยท LLY

Eli Lilly and Company reported revenue of $24.4 billion for the quarter ended September 30, 2026, an increase of 38.6% from the same quarter a year earlier ($17.6 billion).

For the same period it posted net income of $6.45 billion, up 15.5%, or $7.22 per diluted share (6.21 a year earlier).

That is a net margin of 26.4%.

On Sanad's AAOIFI Standard 21 screen, Eli Lilly and Company is currently compliant: interest-bearing debt is 3.7% of market capitalisation (limit 30%), and impure income is 0.2% of revenue (limit 5%).

Source: 10-Q filed with the U.S. Securities and Exchange Commission on October 29, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.

More Eli Lilly and Company news